Hypertrophic cardiomyopathy, long QT interval and coronary perforator disease in the Noonan syndrome

被引:0
|
作者
de Gregorio, Cesare [1 ,2 ]
Recupero, Antonino [2 ]
机构
[1] Univ Hosp Messina, Dept Clin & Expt Med, Cardiol Unit, Messina, Italy
[2] Univ Hosp Messina, Dept Emergency, Cardiol Unit, Messina, Italy
关键词
coronary artery disease; echocardiography; heart failure; hypertrophic cardiomyopathy; long QT syndrome; Noonan syndrome;
D O I
10.2459/JCM.0000000000000881
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:161 / 163
页数:3
相关论文
共 50 条
  • [31] Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition
    Andelfinger, Gregor
    Marquis, Christopher
    Raboisson, Marie-Josee
    Theoret, Yves
    Waldmuller, Stephan
    Wiegand, Gesa
    Gelb, Bruce D.
    Zenker, Martin
    Delrue, Marie-Ange
    Hofbeck, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (17) : 2237 - +
  • [32] Membranous septal aneurysm in a child with Noonan syndrome and hypertrophic cardiomyopathy
    Arunakumar, Priyadarshini
    Sastry, Usha M. K.
    Satyamurthy, Ramya Guddekeri
    Jayaranganath, M.
    INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 38 (04) : 448 - 450
  • [33] Prenatal Hypertrophic Cardiomyopathy and Neonatal Noonan Syndrome: an Association to Remember
    Sanchez Andres, Antonio
    Moriano Gutierrez, Ana
    Carrasco Moreno, Jose Ignacio
    REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (06): : 537 - 538
  • [34] Psychological impact of sports restriction in asymptomatic adolescents with hypertrophic cardiomyopathy, dilated cardiomyopathy, and long QT syndrome
    Berg, Alizabeth E.
    Meyers, Lindsay L.
    Dent, Karin M.
    Rothwell, Erin W.
    Everitt, Melanie D.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2018, 49 : 57 - 62
  • [35] Dynamics of QT interval in a patient with long QT syndrome and a normal QT interval
    Nakagawa, M
    Iwao, T
    Ishida, S
    Takahashi, N
    Yonemochi, H
    Asada, M
    Shimada, S
    Saikawa, T
    Ito, M
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1998, 62 (03): : 215 - 218
  • [36] Prevalence, Clinical Presentation, and Management of Channelopathies and Cardiomyopathies, Long QT Syndrome, Brugada Syndrome, Arrhythmogenic Cardiomyopathy, and Hypertrophic Cardiomyopathy
    Kristina H. Haugaa
    Ida S. Leren
    Current Cardiovascular Risk Reports, 2019, 13
  • [37] Prevalence, Clinical Presentation, and Management of Channelopathies and Cardiomyopathies, Long QT Syndrome, Brugada Syndrome, Arrhythmogenic Cardiomyopathy, and Hypertrophic Cardiomyopathy
    Haugaa, Kristina H.
    Leren, Ida S.
    CURRENT CARDIOVASCULAR RISK REPORTS, 2019, 13 (07)
  • [38] Fibromuscular dysplasia of coronary arteries resulting in myocardial infarction associated with hypertrophic cardiomyopathy in Noonan's syndrome
    Ishikawa, Y
    Sekiguchi, K
    Akasaka, Y
    Ito, K
    Akishima, Y
    Zhang, LJ
    Itoh, M
    Ishihara, M
    Ishii, T
    HUMAN PATHOLOGY, 2003, 34 (03) : 282 - 284
  • [39] Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?
    Ackerman, MJ
    CURRENT OPINION IN CARDIOLOGY, 2005, 20 (03) : 175 - 181
  • [40] Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: A study from the Pediatric Cardiomyopathy Registry
    Wilkinson, James D.
    Lowe, April M.
    Salbert, Bonnie A.
    Sleeper, Lynn A.
    Colan, Steven D.
    Cox, Gerald F.
    Towbin, Jeffrey A.
    Connuck, David M.
    Messere, Jane E.
    Lipshultz, Steven E.
    AMERICAN HEART JOURNAL, 2012, 164 (03) : 442 - 448